China Oncology ›› 2021, Vol. 31 ›› Issue (4): 250-256.doi: 10.19401/j.cnki.1007-3639.2021.04.002

• Specialists’ Commentary • Previous Articles     Next Articles

Leading research progress and prospect of gynecological oncology in 2020

ZHU Jun, WU Xiaohua   

  1. Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Online:2021-04-30 Published:2021-04-28
  • Contact: WU Xiaohua E-mail: docwuxh@yahoo.com

Abstract: There have been many leading research achievements in the past year in the field of gynecologic oncology. Breakthroughs in surgical treatment, adjuvant therapy and targeted therapy have been made in the common gynecological malignancies, including cervical cancer, uterine cancer and ovarian cancer. Targeted therapy has greatly improved the prognosis of patients with ovarian cancer. For a specific
kind of ovarian cancer patients, targeted therapy has resulted in significant survival improvement. In terms of surgical treatment, more research has been conducted on the safety of radical laparoscopic surgery for cervical cancer compared with laparotomy surgery. Surgical modality for endometrial cancer is constantly updated and explored as well.

Key words: Ovarian cancer, Cervical cancer, Uterine cancer, Chemotherapy, Targeted therapy